A structured tapering plan, combined with healthy habits, is essential for maintaining progress after stopping GLP-1 therapy
Wernicke encephalopathy associated with semaglutide use
Individuals who are overweight or have a Body Mass Index (BMI) of 30 or higher, indicating obesity People with health issues such as diabetes, high blood pressure, or high cholesterol Those who are in the process of weight loss and require additional support Individuals seeking to reduce unhealthy snacking habits People who have not seen results from other weight-loss methods, such as non-standard weight loss medications Anyone looking for a safe weight-loss solution with no side effects or risk of yo-yo weight gain Who Should Not Use the GLP-1
These have different considerations during illness: Shorter Half-Life : Medication clears your system faster, so missing a day has more immediate effects on appetite and blood sugar (for those with diabetes)
(Imagine: being able to stop at one cookie
The mass media have reported shortages of the drugs caused by high demand volumes
